熱門資訊> 正文
Plus Therapeutics宣布从CPRIT预付160万美元
2025-07-23 19:41
- Plus Therapeutics (NASDAQ:PSTV) Wednesday said that it has received notice of an advance payment of $1.6 million from the Cancer Prevention and Research Institute of Texas.
- The payment is part of the company’s previously awarded $17.6 million grant.
- "This latest CPRIT disbursement and additional funding expected to be received over the next 12 months of approximately $6 million continues to provide significant non-dilutive financing,” said Andrew Sims, Plus Therapeutics Chief Financial Officer.
More on Plus Therapeutics
- Plus Therapeutics drops 5%, files prospectus for 17M share secondary offering
- Plus Therapeutics receives Nasdaq delinquency notice
- Seeking Alpha’s Quant Rating on Plus Therapeutics
- Historical earnings data for Plus Therapeutics
- Financial information for Plus Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
